Anti-Müllerian Hormone Attenuates the Effects of FSH on Follicle Development in the Mouse Ovary.

By Alexandra L. L. Durlinger, Maria J G Gruijters, P. Kramer, B. Karels, T. Kumar, M. Matzuk, U. M. Rose, F. de Jong, J. Uilenbroek, J. Grootegoed and 1 more. Endocrinology, 2001

629 citations recorded by the source corpus.

Subfields: Public Health, Environmental and Occupational Health, Reproductive Medicine

View Paper: https://www.semanticscholar.org/paper/c31f5687f38223ff60f348512065bb71a71518f6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Public Health, Environmental and Occupational Health

1. Bart C. J. M. Fauser
2. Frank J. Broekmans
3. M. Matzuk

In Reproductive Medicine

1. Bart C. J. M. Fauser
2. J. Laven
3. Frank J. Broekmans
4. S. Broer
5. M. Matzuk

Citations in the corpus

• Regulation of ovarian function: the role of anti-Müllerian hormone. (2002, background): “The inhibitory effect of AMH on FSH-stimulated follicle growth was also confirmed in an in vivo model in which follicle growth in the presence of high or low serum FSH concentrations was compared between AMHKO females and their wild-type littermates (Durlinger et al., 2001).”
• Genetic Analysis of the Mammalian Transforming Growth Factor-β Superfamily (2002, background): “Follow-up studies with MIS null and FSH null females showed that MIS also inhibits FSH-stimulated follicle growth, and primordial follicle recruitment is enhanced in the absence of both MIS and FSH but not FSH alone (319).”
• Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. (2003, background): “In addition, growing evidence indicates that AMH mainly is expressed in pre-antral and early antral follicles (Baarends et al., 1995) and has either direct or indirect roles in various phases of folliculogenesis, from the primordial (Durlinger et al., 2002) to FSH-sensitive ( Durlinger et al., 2001;”
• Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. (2002, background): “Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve”
• Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. (2004, background): “Moreover, ovarian follicles of AMHKO mice treated in vivo with exogenous FSH appear to be more sensitive to FSH compared with follicles from wild type mice, resulting in an increased number of follicles reaching the ovulatory stage compared with wild type mice (Durlinger et al., 1999, 2001).”
• Methods for quantifying follicular numbers within the mouse ovary. (2004, background): “…follicular numbers range from 57 between days 50 and 70 (Smith et al. 1991) to 6800 at day 53 (Benedict et al. 2000), with many variations in between (Pedersen, 1972, Ratts et al. 1995, Durlinger et al. 2001, Flaws et al. 2001, Danilovich & Sairam 2002, Tomic et al. 2002, Canning et al. 2003).”
• Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). (2010, background): “compared with wild-type and AMH null mice in the presence of low and high FSH serum concentrations (Durlinger et al., 2001).”
• Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications. (2014, background): “As antral follicles become larger, the AMH expression diminishes and this could reduce the threshold level for FSH, allowing follicles to continue growing and to ovulate in the next estrous cycle (Durlinger et al., 2001; Al Qahtani et al., 2005; Visser et al., 2007).”